Biotech · Private company · Reno, NV, US
Zywie, Inc.
Track this companyFree. Adds Zywie, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Phase 1 Test Device Sensor and Adhesive and Reference DeviceHealthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Phase 2 Test Device ECG Signal quality over a 10-day simulated use periodHealthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Test Algorithm and Test DeviceAtrial Fibrillation (AF)ClinicalTrials.gov · fetched Nov 12, 2026
- Test Device Sensor and Adhesive Variable PlacementHealthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of a Test Algorithm for Use to Analyze ECG Data Collected From a Test Device of a 24-hour Simulated Use PeriodNA · COMPLETED · started Jan 20, 2025ClinicalTrials.gov NCT07188129 · fetched Nov 12, 2026
- A Three-phase Study That Will Compare the ECG Data Recorded Using the Test Device With the Data Recorded by a Reference Device, Evaluate the ECG Signal Quality of the Test Device Over a 10-day Simulated Use Period, and Assess the Effects of Variable ECG Electrode Placement for the Test DeviceNA · COMPLETED · started Jan 15, 2025ClinicalTrials.gov NCT07200232 · fetched Nov 12, 2026
NIH awards1
- Developing Novel Ambroxol Analogs as Disease-Modifying Therapies for Alzheimer's Disease and Related DementiasFiscal year 2025 · $496.6KNIH RePORTER 1R43AG097283-01 · fetched Nov 12, 2026